Background:Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis. In addition to skin and joint involvement, there is a growing evidence suggesting that patients with PsA also have increased risk of clinical and subclinical cardiovascular disease (CVD), mostly due to endothelial dysfunction and accelerated atherosclerosis, which are the main causes of elevated mortality rate among patients with PsA. For prevention and monitoring progression of CVD in clinical practice scale SCORE usually used, but it isn’t adapted for checking in patients with autoimmune diseases and can be used only for patients after forty years old.Objectives:To check a cardiovascular risk in patient with PsA using Q-risk scale.Methods:In total, ninety-four patients with PsA, who fulfilled the disease criteria (CASPAR) were examined using standard diagnostic methods (including C-reactive protein, lipid profile). The QRISK-3 and SCORE scales were used to assess the 10-year risk of CVD.Results:Intermediate (12.4 ± 0,75 %) risk of adverse cardiovascular events within the next 10 years was estimated for PsA patients and it was 7 to 8 – fold higher than the Q - score of a healthy age, sex, and ethnicity – matched subjects. Using classical SCORE, the risk was estimated as low (1,9±0.24 %). Healthy Heart Age was about 25 % higher than predicted as assessed by QRISK.Conclusion:The Q-risk Scale considers not only classical of such risk factors as age, sex, smoking, systolic blood pressure, total cholesterol (which used SCORE) but also index of atherogenity, BMI, family history of coronary artery disease, treatment with antihypertensive drugs and glucocorticosteroids, comorbidity, systemic inflammatory disease and can be used for different age groups and ethnicity.Q-risk scale appears to be adaptive and informative in patients with chronic inflammatory and autoimmune diseases as compared with SCORE, because it uses mostly all important etiological and trigger factors of CVD especially presence autoimmune inflammatory process in our case.References:[1]Abrar Ahmed Wagan. Cardiovascular risk score in Rheumatoid Arthritis. Pak J Med Sci, Vol. 32, Issue 3, 2016, P.534-538;[2]Frank Verhoeven, Clément Prati. Cardiovascular risk in psoriatic arthritis, a narrative review. Joint Bone Spine, Vol. 87, Issue 5, 2020, P.413-418;[3]Julia Hippisley-Cox, Carol Coupland. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ, Vol. 23, 2017, P.357;[4]Naveen Garg, Subrat K. Muduli. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. Indian Heart J, Vol. 69, Issue 4, 2017, P.458-463;Disclosure of Interests:None declared.